neoplasm
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)TIAP was implanted in the chest wall, 2)the end of the infusion port catheter was well positioned from the lower 1/3 of the superior vena cava to the connection between the superior vena cava and the right atrium, 3) the expected follow-up treatment time exceeds 6 months; 4)more than 18 years old, 5)patients were aware of their condition, 6) informed consent to participate in this study.
Exclusion criteria
Exclusion criteria: 1) skin surface lesions at the site of TIAP, 2) EMLA cream or dressing allergy or drug allergen unknown, 3)local lymph node metastasis at the site of TIAP, 4).significant coagulation disorders, 5).pain or treatment with analgesic drugs now, 6)receiving drugs with local anesthetic components, 7)patients with psychiatric disorders who are unable to cooperate with the complete survey
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| complication; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain;Skin irritation response;Comfort; | — |
Countries
China
Contacts
Sun Yat-sen University Cancer Center